Sage Therapeutics Inc. Register financial reports, Sage Therapeutics Inc. Register annual revenue in 2024. When does Sage Therapeutics Inc. Register report revenue?
Sage Therapeutics Inc. Register total revenue, net income and dynamics of changes in Euro today
Sage Therapeutics Inc. Register revenue for the past few reporting periods. Net revenue of Sage Therapeutics Inc. Register on 30/06/2021 amounted to 1 643 000 €. Sage Therapeutics Inc. Register net income is now -107 245 000 €. Graph of the financial report of Sage Therapeutics Inc. Register. Sage Therapeutics Inc. Register financial report on the graph shows the dynamics of assets. Sage Therapeutics Inc. Register net income is shown in blue on the graph.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021
1 541 051.85 €
+88.2 % ↑
-100 590 447.75 €
-
31/03/2021
1 484 774.85 €
+240.43 % ↑
-89 821 843.80 €
-
31/12/2020
1 040 361 008.70 €
+56 491.120 % ↑
914 402 765.25 €
-
30/09/2020
1 537 300.05 €
-54.0896 % ↓
-99 174 143.25 €
-
31/12/2019
1 838 382 €
-
-158 188 081.35 €
-
30/09/2019
3 348 481.50 €
-
-168 791 606.10 €
-
30/06/2019
818 830.35 €
-
-157 782 886.95 €
-
31/03/2019
436 146.75 €
-
-153 266 657.70 €
-
Show:
to
Sage Therapeutics Inc. Register financial report charts
Dates of Sage Therapeutics Inc. Register finance reports: 31/03/2019, 31/03/2021, 30/06/2021. The dates of financial statements are strictly regulated by law and financial statements. The latest date of the financial report of Sage Therapeutics Inc. Register is 30/06/2021. Gross profit Sage Therapeutics Inc. Register is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Sage Therapeutics Inc. Register is -64 675 000 €
Sage Therapeutics Inc. Register quarterly report dates
Cost of revenue Sage Therapeutics Inc. Register is the total cost of producing and distributing of products and services of a company. Cost of revenue Sage Therapeutics Inc. Register is 66 318 000 € Total revenue Sage Therapeutics Inc. Register refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Sage Therapeutics Inc. Register is 1 643 000 € Operating income Sage Therapeutics Inc. Register is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Sage Therapeutics Inc. Register is -108 021 000 €
Net income Sage Therapeutics Inc. Register is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Sage Therapeutics Inc. Register is -107 245 000 € Current assets Sage Therapeutics Inc. Register is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Sage Therapeutics Inc. Register is 1 988 599 000 € Total assets Sage Therapeutics Inc. Register refers to the total amount of assets owned by a person or entity. Total assets Sage Therapeutics Inc. Register is 2 015 475 000 €
30/06/2021
31/03/2021
31/12/2020
30/09/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-60 661 916.25 €
-53 144 247 €
963 597 304.80 €
-68 083 914.60 €
-83 954 966.55 €
-92 552 216.25 €
-82 755 328.50 €
-80 600 857.35 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
62 202 968.10 €
54 629 021.85 €
76 763 703.90 €
69 621 214.65 €
85 793 348.55 €
95 900 697.75 €
83 574 158.85 €
81 037 004.10 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
1 541 051.85 €
1 484 774.85 €
1 040 361 008.70 €
1 537 300.05 €
1 838 382 €
3 348 481.50 €
818 830.35 €
436 146.75 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-101 318 296.95 €
-90 518 740.65 €
913 418 855.70 €
-101 005 021.65 €
-163 801 712.10 €
-175 562 667.15 €
-165 507 843.15 €
-159 312 683.40 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-100 590 447.75 €
-89 821 843.80 €
914 402 765.25 €
-99 174 143.25 €
-158 188 081.35 €
-168 791 606.10 €
-157 782 886.95 €
-153 266 657.70 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
54 453 625.20 €
54 453 625.20 €
54 453 625.20 €
-
-
-
-
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
102 859 348.80 €
92 003 515.50 €
126 942 153 €
102 542 321.70 €
165 640 094.10 €
178 911 148.65 €
166 326 673.50 €
159 748 830.15 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
1 865 206 432.05 €
1 924 547 714.70 €
1 990 676 941.50 €
655 518 247.80 €
970 865 479.35 €
1 081 140 260.85 €
1 185 165 481.50 €
1 286 428 439.40 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
1 890 414 776.25 €
1 951 590 689.10 €
2 025 264 785.70 €
692 796 132.60 €
1 016 878 492.50 €
1 129 035 739.65 €
1 233 917 308.65 €
1 334 622 186.30 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
482 254 496.10 €
843 451 537.50 €
1 558 011 861.90 €
172 836 046.50 €
118 842 954.75 €
243 098 818.95 €
155 873 220.75 €
321 055 595.25 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
105 170 457.60 €
85 312 180.20 €
74 053 966.35 €
64 133 269.20 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
130 839 335.25 €
115 045 195.20 €
105 680 702.40 €
96 965 271 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
12.87 %
10.19 %
8.56 %
7.27 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
1 809 785 780.40 €
1 878 972 724.20 €
1 943 745 675.30 €
616 778 098.95 €
886 039 157.25 €
1 013 990 544.45 €
1 128 236 606.25 €
1 237 656 915.30 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-109 483 151.70 €
-120 716 040.90 €
-125 070 004.80 €
-140 630 595.30 €
Last revenue report of Sage Therapeutics Inc. Register was 30/06/2021. According to last financial report total revenue in Sage Therapeutics Inc. Register was 1 541 051.85 Euro and changed by +88.2% since last year. Net income in Sage Therapeutics Inc. Register was -100 590 447.75 € in last quartal, net income changes to 0%.
Current cash Sage Therapeutics Inc. Register - the sum of all of the cash a company has on the date of report. Current cash Sage Therapeutics Inc. Register is 514 158 000 €
Sage Therapeutics Inc. Register stocks data
SG7.SG stock price
Sage Therapeutics Inc. Register stock price today, SG7.SG stock quote.
